Breast Cancer

Showing NaN - NaN of 237

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With Leptomeningeal Metastases ((LM) Using CNSide

Recruiting
  • Leptomeningeal Metastasis
  • +4 more
  • CNSide
  • Los Angeles, California
    Valkyrie Clinical Trials
Sep 7, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Chandler, Arizona
  • +226 more
Aug 11, 2022

Breast Cancer Trial in Los Angeles (Nature based exercise)

Recruiting
  • Breast Cancer
  • Nature based exercise
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 2, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Chandler, Arizona
  • +166 more
Jul 21, 2022

Cancer, Breast Cancer, Colon Cancer Trial in Los Angeles (Change in knowledge, motivation, skills, and resources)

Withdrawn
  • Cancer
  • +4 more
  • Change in knowledge, motivation, skills, and resources
  • Los Angeles, California
    Charles R. Drew University of Medicine & Science
Jul 22, 2022

Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +167 more
Jul 19, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alaska
  • +495 more
Jun 15, 2022

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

Withdrawn
  • Breast Cancer
  • +3 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 28, 2022

Breast Cancer Trial in Los Angeles (Carbohydrate restricted dietary intervention, standard of care aromatase inhibitors)

Recruiting
  • Breast Cancer
  • Carbohydrate restricted dietary intervention
  • standard of care aromatase inhibitors
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 30, 2022

Breast Cancer Trial in Worldwide (Amcenestrant (SAR439859), Letrozole)

Terminated
  • Breast Cancer
  • Tucson, Arizona
  • +31 more
Jun 27, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)

Active, not recruiting
  • Breast Cancer
  • therapeutic conventional surgery
  • whole breast irradiation
  • Hot Springs, Arkansas
  • +349 more
Jun 16, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in Los Angeles (Omit breast radiation)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Omit breast radiation
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 10, 2022

Breast Cancer Trial in United States (radiation, drug, biological)

Recruiting
  • Breast Cancer
  • Focal Radiation therapy
  • +2 more
  • Los Angeles, California
  • +6 more
Apr 29, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +437 more
Mar 21, 2022

Breast Cancer Trial in Los Angeles (Diabetes Prevention Program-based lifestyle change intervention (DPP), Highly

Recruiting
  • Breast Cancer
  • Diabetes Prevention Program-based lifestyle change intervention (DPP)
  • Highly Microbiota-Accessible Foods (HMAFs) intervention
  • Los Angeles, California
    UCLA Center for Cancer Prevention & Control Research
Apr 1, 2022